.Merck beats incomes expectations, rears sales outlook on tough demand for leading drugs like Keytruda CNBCMerck & Co. (MRK United States) Beats Revenue Forecasts as Keytruda Purchases Surge BloombergMerck Supply: Pharma Titan Posts Strong End Results, However Overview Drops Short Capitalist's Company DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck beats revenue and sales expectations in the middle of Keytruda advantage, yet supplies mixed full-year expectation MarketWatch.